test44
https://www.cytel.com/blog/covid-19-trials-designs-and-tools-for-promising-results-panel-discussion
May 7, 2020
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread..
Read article
test44
https://www.cytel.com/blog/webinar-a-clinicians-perspective-on-cancer-drugs-development
May 5, 2020
Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars..
Read article
test44
https://www.cytel.com/blog/a-clinicians-perspective-on-cancer-drugs-development-an-interview-with-martin-fey
April 23, 2020
Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,..
Read article
test44
https://www.cytel.com/blog/clinical-trial-optimization-with-r
November 28, 2017
In this blog we turn to some reading matter, and interview Gautier Paux and Alex Dmitrienko about the recent book..
Read article
test44
https://www.cytel.com/blog/cytel-story-30-years
November 9, 2017
In this blog we are excited to unveil a new project which we have been hard at work on over the last few months. 2017..
Read article
test44
https://www.cytel.com/blog/accelerating-development-combined-sad-mad
January 30, 2017
Single ascending dose (SAD) and multiple ascending dose (MAD) studies are typically the first in human studies. They..
Read article
test44
https://www.cytel.com/blog/regulatory-go-ahead-for-adaptive-design
January 23, 2017
As a group, Cytel had over 40 successful regulatory interactions last year, many of which supported approvals for..
Read article
test44
https://www.cytel.com/blog/blinded-ssr-biosimilar
April 7, 2016
Francois Beckers, Global Head of Biostatistics & Epidemiology at Merck KGaA joined us at the East User Group Meeting..
Read article
test44
https://www.cytel.com/blog/decision-making-early-clinical
March 29, 2016
On March 16th and 17th the 5th East User Group Meeting took place in London. This very successful 2 days saw a variety..
Read article
